Gerresheimer AG (ETR:GXI – Get Free Report)’s share price was up 1.7% during trading on Wednesday . The stock traded as high as €67.80 ($70.63) and last traded at €67.80 ($70.63). Approximately 142,949 shares traded hands during trading, an increase of 1% from the average daily volume of 140,925 shares. The stock had previously closed at €66.65 ($69.43).
Gerresheimer Price Performance
The company has a 50 day moving average of €71.16 and a 200 day moving average of €84.90. The firm has a market cap of $2.34 billion, a price-to-earnings ratio of 20.42, a P/E/G ratio of 0.82 and a beta of 0.94. The company has a current ratio of 0.87, a quick ratio of 0.40 and a debt-to-equity ratio of 79.36.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
See Also
- Five stocks we like better than Gerresheimer
- Top Stocks Investing in 5G Technology
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How Technical Indicators Can Help You Find Oversold StocksÂ
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Fintech Stocks With Good 2021 Prospects
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.